All In Biotech

Free tool

FAERS Monitor: Crexont

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 217186 or its brand name (Crexont, Carbidopa, Levodopa). Reports on generic versions are filed under their own applications.

Reports

5,848

Serious

3,390

58% of reports

Hospitalization

1,565

Death reported

622

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective659
  • fall514
  • hallucination512
  • dyskinesia443
  • tremor386
  • nausea317
  • dizziness306
  • death296
  • fatigue281
  • gait disturbance275
  • cough270
  • parkinson^s disease263
  • confusional state259
  • somnolence258
  • condition aggravated256

Reports by year received

View as table
YearReports
200496
200592
200685
2007107
2008224
2009122
2010150
2011141
2012134
201331
201467
2015121
2016192
2017408
2018380
2019293
2020418
2021299
2022272
2023194
2024310
20251,044
2026668

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,311 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
dyskinesiaSignal44339.636.216,491
hallucinationSignal51224.622.611,528
tremorSignal3868.47.62,516
confusional stateSignal2595.85.11,023
fallSignal5145.65.11,946
gait disturbanceSignal2755.24.6929
somnolenceSignal2584.64.1733
coughSignal2703.53.1477
condition aggravatedSignal2563.02.7351
dizzinessSignal3062.22.0206
drug ineffective6591.81.7248
nausea3171.41.344
fatigue2811.31.220
death2961.21.114
parkinson^s disease2630.00.0943,013

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.